Literature DB >> 23914318

Value of thyroid and rheumatologic studies in the evaluation of peripheral neuropathy.

Gary Gallagher1, Amanda Rabquer, Kevin Kerber, Bernadette Calabek, Brian Callaghan.   

Abstract

Peripheral neuropathy is a common disorder, often prompting an extensive initial laboratory evaluation. The initial evaluation is particularly challenging to primary care physicians and neurologists because of the broad differential diagnosis. Although screening thyroid and rheumatologic tests are frequently ordered, the diagnostic yield of these tests is unclear. Data from our institution were collected on patient demographics, clinical characteristics including warning signs suggestive of a diagnosis other than distal symmetric polyneuropathy, history of thyroid or rheumatologic disease, and laboratory tests ordered. Thyroid and rheumatologic screening tests are commonly ordered in the evaluation of peripheral neuropathy. Our findings suggest a low aggregate value of these tests based on low yield and infrequent changes in the suspected etiology or management of these patients.

Entities:  

Year:  2013        PMID: 23914318      PMCID: PMC3721242          DOI: 10.1212/CPJ.0b013e31828d9f2c

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  15 in total

1.  Erythrocyte sedimentation rate and age.

Authors:  G S Hayes; I N Stinson
Journal:  Arch Ophthalmol       Date:  1976-06

2.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

3.  Serum anti-gamma-globulin and antinuclear factors in the aged.

Authors:  R J Cammarata; G P Rodnan; R H Fennell
Journal:  JAMA       Date:  1967-02-13       Impact factor: 56.272

4.  The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice.

Authors:  Brian C Callaghan; Kevin Kerber; Andrea L Smith; A Mark Fendrick; Eva L Feldman
Journal:  Arch Neurol       Date:  2011-11-14

5.  Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study.

Authors:  R F Duyff; J Van den Bosch; D M Laman; B J van Loon; W H Linssen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

6.  Hypothyroidism and polyneuropathy.

Authors:  E Beghi; M L Delodovici; G Bogliun; V Crespi; F Paleari; P Gamba; M Capra; M Zarrelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

7.  A rational diagnostic approach to peripheral neuropathy.

Authors:  A Gordon Smith; Mark B Bromberg
Journal:  J Clin Neuromuscul Dis       Date:  2003-06

Review 8.  Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation.

Authors:  J D England; G S Gronseth; G Franklin; G T Carter; L J Kinsella; J A Cohen; A K Asbury; K Szigeti; J R Lupski; N Latov; R A Lewis; P A Low; M A Fisher; D N Herrmann; J F Howard; G Lauria; R G Miller; M Polydefkis; A J Sumner
Journal:  Neurology       Date:  2008-12-03       Impact factor: 9.910

9.  The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy.

Authors:  A Gordon Smith; J Robinson Singleton
Journal:  Arch Intern Med       Date:  2004-05-10

10.  High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.

Authors:  M N Manoussakis; A G Tzioufas; M P Silis; P J Pange; J Goudevenos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

View more
  4 in total

1.  Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy.

Authors:  Magdalena Lang; Roi Treister; Anne Louise Oaklander
Journal:  J Neurol       Date:  2016-10-11       Impact factor: 4.849

Review 2.  Distal Symmetric Polyneuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Eva L Feldman
Journal:  JAMA       Date:  2015-11-24       Impact factor: 56.272

3.  IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety.

Authors:  Xiaolei Liu; Roi Treister; Magdalena Lang; Anne Louise Oaklander
Journal:  Ther Adv Neurol Disord       Date:  2018-01-08       Impact factor: 6.570

4.  Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants.

Authors:  Mary A Kelley; Anne Louise Oaklander
Journal:  Can J Pain       Date:  2020-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.